Matt Weir & I offer an obituary of our affable colleage George Bakris ahajournals.org/doi/abs/10.116… "With a diagnosis of cancer 4 years ago, pain was inevitable. But how to respond to this crisis was a choice. Dr Bakris inspired us by publishing >200 papers while battling his disease."

The George M. O’Brien Kidney Resource Alliance (OKRA, uab.edu/okra/) announces an Opportunity Pool Program offering to support large pilot grants (up to a maximum of $50,000 total costs) addressing scientific and technological gaps in kidney research and promoting new

For the past few months we have been facing a serious shortage of Hepatitis B vaccine in India CKD patients who are undergoing hemodialysis needs mandatory Hepatitis B vaccine and many new born needs hepatitis B vaccine There is an urgent need to address this issue

The World Congress of Nephrology will be held in New Delhi in February 2025. #ISNWCN Apply for a travel grant here 👉 theisn.org/wcn/travel-gra…

🧵2/2 Have your say and help us guide the next three years of research! 🚀 Learn more and participate here: tinyurl.com/yncf8smb #KidneyHealth #CardioResearch #DataScience #BHF

If you work in #nephrology & have interest in #ethics &/or #education, please join us 13/9 for discussion of why and how you can help support development of a global ethics curriculum for kidney care. With Priya Pais Jordan A. Parsons 🍉 Lilia Cervantes Dr Benita Padilla & more!

🚨 Deadline Tomorrow! 🚨 Last chance to save $200 on #KidneyWk registration! Join 12,000+ kidney professionals at Kidney Week 2024 in San Diego for the latest in kidney health. ➡️ asn.kdny.info/qsJ750Spsh2

Nephrology Journal Club For #NephJCKidneys manuscript of the year, it seems pretty obvious, would go with the FLOW #glipinate nephjc.com/news/flow

The PROTECTION mafia #NephJC discussion on Freely Filtered: A NephJC Podcast pod Joel M. Topf, MD FACP Joshua Waitzman, MD PhD and Jennie Lin 👩🏻‍⚕️🧬 with special AKI experts Jay Koyner and J Pedro Teixeira (a.k.a. Jwow)

Time to rebrand GLP-1 agonists as disease modifying agents in type 2 diabetes. We use them far too late (in the UK because of cost-effective NG28). If we get in early with them, I think we’d be inducing metabolic recovery in most people with type 2 diabetes and saying goodbye

👋Join us in #Chicago 💃💓TODAY AHAMeetings #Hypertension24 Andrew Michael South, MD, MS Dr Anastasia Mihailidou FAHA FCSANZ FESC Junie P Warrington, PhD, FAHA Stephen Juraschek MD, PhD, FAHA, AHSCP-CHS DeniseLevy@Heart Swapnil Hiremath @[email protected] Council on Hypertension Hypertension Paul A Welling Hinal Rathi, DO @ialinasehar Soumyadeep Bag, MD Carmen De Miguel, PhD, MS, FAHA 💃👠👔👟🤓

New Deadline for WCN’25 Abstracts‼️ If you've submitted your #ISNWCN abstract or are still finalizing it, you now have 10 more days to submit it. Don’t miss the chance to impact the future of kidney care by sharing your research with a global audience. The new deadline also

#askrenal @askrenal Do You Routinely Prescribe antihypertensives on non-dialysis days (hold dialysis days) for in-center HD pts? Any evidence? Any particular agents? What clinical scenario you would? Swapnil Hiremath @[email protected] Joel M. Topf, MD FACP SMH Hemodialysis Jade Teakell MD PhD SMH Hemodialysis Nikhil Shah MBBS DNB(IM, Neph)🇨🇦

A session that could not have happened a few years ago! Mechanistic session - but all these drugs are approved or in phase 3 RCTs - a glorious time to be in hypertension #Hypertension24

Hey FAHA peeps - make sure to pick up your pin at the AHA Science membership booth at #Hypertension24

Coming up 430p is our debate on management strategies for resistant hypertension (Salon A5/Lower Level) with experts Jennifer Cluett, MD Debbie Cohen MD 🇮🇱 🇺🇸🇿🇦 ... Lifestyle is best both worth hearing them out! AHA Science AHAMeetings #Hypertension24

JGIM is having a special issue on Learning Health Systems in General Medicine. Please submit! Also, contact us with questions. Abstracts Due: September 30, 2024 Final Manuscripts Due: December 16, 2024 sgim.org/news/call-for-…

Really neat implementation study on primary aldosterone screening presented by Laboratory of Vivek Bhalla, MD- Stanford AHA Science AHAMeetings #Hypertension24

Primary aldosteronism screening myths presented by Laboratory of Vivek Bhalla, MD- Stanford AHA Science AHAMeetings #Hypertension24

Lots of interest in primary aldosteronism at #Hypertension24 If you enjoyed our PA session then you should also watch this seminar